Form 4: Core Scientific Officer Sells Shares Under 10b5-1 Plan

Core Scientific, Inc. officer Todd DuChene reported the sale of common stock through a pre-arranged trading plan.

Summary

• Todd DuChene, Chief Legal and Administrative Officer of Core Scientific, Inc., reported transactions on April 13, 2026.
• These transactions involved the sale of 9,600 shares of common stock at a weighted average price of $18.6094.
• An additional 400 shares were sold at a weighted average price of $18.9925.
• The sales were executed under a Rule 10b5-1 trading plan adopted on December 5, 2025.
• Following these transactions, DuChene beneficially owns 2,027,489 shares of common stock.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral filing, as the transactions were conducted under a pre-established Rule 10b5-1 plan, indicating a planned divestment rather than a reaction to current company performance.

Negatives

• Officer Todd DuChene sold a total of 10,000 shares of common stock.

Future Outlook

No specific future outlook or guidance is provided in this filing, as it solely reports past transactions.

Industry Context

StockSavvy.ai notes that insider sales, especially when conducted under a Rule 10b5-1 plan, are common and often reflect personal financial planning rather than a negative view of the company's prospects. However, significant sales by key officers can sometimes be interpreted by the market as a signal.

Stakeholder Impact

• Shareholders may note the sale of shares by a key officer, though the Rule 10b5-1 plan mitigates concerns about insider trading based on material non-public information.

Key Dates

Keywords

Core Scientific, CORZ, Form 4, insider trading, Rule 10b5-1, stock sale, officer transaction